Biocompatibles Archive

Biocompatibles Archive

  1. Director/PDMR Shareholding

  2. Director/PDMR Shareholding

  3. Statement re Agreement with AstraZeneca

  4. Second Price Monitoring Extn

  5. Price Monitoring Extension

  6. Holding(s) in Company

  7. Filing for CE Mark Approval...

  8. Research Update

  9. Director/PDMR Shareholding

  10. Price Monitoring Extension

  11. Director/PDMR Shareholding

  12. Director/PDMR Shareholding

  13. High Court Approval

  14. Second Price Monitoring Extn

  15. Price Monitoring Extension

  16. Interim Management Statement

  17. Director/PDMR Shareholding

  18. Blocklisting - Interim Review

  19. Blocklisting - Interim Review

  20. Holding(s) in Company

  21. Total Voting Rights

  22. Director/PDMR Shareholding

  23. Holding(s) in Company

  24. Statement re Clinical Collaboration Agreement

  25. Director/PDMR Shareholding

  26. Total Voting Rights

  27. Research Update

  28. Additional Listing

  29. Price Monitoring Extension

  30. Director/PDMR Shareholding

  31. Half-yearly Report

  32. PRECISION V Results

  33. Completion of Acquisition of BrachySciences

  34. Director/PDMR Shareholding

  35. Directorate Change

  36. Acquisition(s)

  37. Director/PDMR Shareholding

  38. Holding(s) in Company

  39. Holding(s) in Company

  40. Total Voting Rights

  41. Director/PDMR Shareholding

  42. AGM Statement

  43. Director/PDMR Shareholding

  44. Holding(s) in Company

  45. Statement re Endeavor Stent...

  46. Holding(s) in Company

  47. Statement re Agreement with Eisai Co. Ltd.

  48. Notice of EGM

  49. Statement re Proposed Dividend

  50. Annual Information Update

  51. Director/PDMR Shareholding

  52. Annual Report and Accounts

  53. Interim Management Statement

  54. Holding(s) in Company

  55. Research Update

  56. Blocklisting - Interim Review

  57. Blocklisting - Interim Review

  58. Director/PDMR Shareholding

  59. Director/PDMR Shareholding

  60. Research Update

  61. Holding(s) in Company

  62. Final Results

  63. Holding(s) in Company

  64. Research Update

  65. Director/PDMR Shareholding

  66. Research Update

  67. Statement re Endeavor Drug-Eluting Stent

  68. Holding(s) in Company

  69. Director/PDMR Shareholding

  70. Director/PDMR Shareholding

  71. Total Voting Rights

  72. Additional Listing

  73. Trading Statement

  74. Director/PDMR Shareholding

  • Email alerts

    Stay up to date and register to receive the latest News and Press Releases by email.

    Email alerts RSS